Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Robert Litman, Dieter Naber, Lourdes Anta, Javier Martínez, Yuriy Filts & Christoph U Correll. (2023) Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Neuropsychiatric Disease and Treatment 19, pages 219-232.
Read now
Read now
Amal Abdel-Baki, Émile Poulin, Sofia Medrano, Paula Pires de Oliveira Padilha, Emmanuel Stip & Stéphane Potvin. (2023) Impact of early use of long-acting injectable antipsychotics on functional outcome in first episode psychosis: a 3-year longitudinal study. International Journal of Psychiatry in Clinical Practice 27:1, pages 25-34.
Read now
Read now
Pedro Such, José Manuel Olivares, Lizbeth Arias, Mette Troels Berg & Jessica Madera. (2021) Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate. Neuropsychiatric Disease and Treatment 17, pages 1881-1892.
Read now
Read now
Articles from other publishers (2)
Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar & Prakash S. Masand. (2021) Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clinical Psychopharmacology and Neuroscience 19:2, pages 233-242.
Crossref
Crossref
Anna Maria Szota & Aleksander Araszkiewicz. (2020) The effectiveness of long-term aripiprazole injections to a patient with paranoid schizophrenia: a case report. Current Problems of Psychiatry 21:3, pages 154-160.
Crossref
Crossref